Epstein‐Barr virus specific T‐cell response in nasopharyngeal carcinoma patients
Denis J. Moss(The University of Queensland), N. Kunaratnam(Singapore General Hospital), John A. Staples(QIMR Berghofer Medical Research Institute), Thean S. Chew(Singapore General Hospital), Soh Ha Chan(National University of Singapore), R. G. Kane(QIMR Berghofer Medical Research Institute), Scott R. Burrows(Australian National University)
Cited by 50
Related Papers
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
|The Journal of Experimental Medicine|1992|391
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
|Proceedings of the National Academy of Sciences|1999|332
A Structural Basis for the Selection of Dominant αβ T Cell Receptors in Antiviral Immunity
|Immunity|2003|323
Estimating the global burden of Epstein–Barr virus-related cancers
|Journal of Cancer Research and Clinical Oncology|2021|313